UBS Group’s Cingulate CING Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.5K Sell
11,033
-16,651
-60% -$106K ﹤0.01% 7198
2025
Q4
$120K Buy
27,684
+26,386
+2,033% +$102K ﹤0.01% 6813
2025
Q3
$5.09K Sell
1,298
-11,347
-90% -$49.1K ﹤0.01% 8898
2025
Q2
$51.5K Sell
12,645
-9,471
-43% -$38.7K ﹤0.01% 7744
2025
Q1
$95.1K Buy
22,116
+9,920
+81% +$43.2K ﹤0.01% 7083
2024
Q4
$60.1K Sell
12,196
-1,553
-11% -$6.8K ﹤0.01% 7183
2024
Q3
$69.3K Buy
+13,749
New +$77.9K ﹤0.01% 6604
2023
Q4
Sell
-1
Closed -$99 9362
2023
Q3
$99 Buy
+1
New +$163 ﹤0.01% 8886
2023
Q2
Sell
-4
Closed -$829 8992
2023
Q1
$829 Sell
4
-24
-86% -$6.39K ﹤0.01% 8892
2022
Q4
$6.72K Sell
28
-35
-56% -$8.63K ﹤0.01% 8993
2022
Q3
$16K Buy
+63
New +$21.8K ﹤0.01% 7675
2022
Q1
Sell
-20
Closed -$13K 10309
2021
Q4
$13K Buy
+20
New +$14.1K ﹤0.01% 8439

Other funds holding CING

UBS Group's CING Position: Q1 2026 in Review

UBS Group reduced its Cingulate (CING) stake by 60% in Q1 2026, selling an estimated $106K and leaving 11,033 shares worth $68.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7198.

UBS Group first reported a position in CING in Q4 2021 and has held it in 12 quarters since. The position peaked at $120K in Q4 2025. 27 funds tracked by Wall St. Rank hold CING as of Q1 2026.

  • UBS Group held 11,033 shares of Cingulate worth $68.5K as of Q1 2026.
  • UBS Group sold 16,651 Cingulate shares in Q1 2026, an estimated $106K.
  • Cingulate made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7198 holding.
  • UBS Group first reported a position in Cingulate in Q4 2021 and has held it in 12 quarters since.
  • UBS Group's Cingulate position peaked at $120K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Cingulate as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.